News
03-17-2015, 10:51 AM
Despite the availability of approximately 25 drugs for the treatment of breast cancer, the unmet need in the global market is vast. To address this drawback, pharmaceutical companies have established a robust pipeline that currently has about 52 drugs in development. While chemotherapy remains the most important class of drugs for breast cancer treatment, the trend toward targeted drugs is on the rise.
More... (http://www.news-medical.net/news/20150317/Global-breast-cancer-therapeutics-market-estimated-to-reach-241338-billion-in-2018.aspx)
More... (http://www.news-medical.net/news/20150317/Global-breast-cancer-therapeutics-market-estimated-to-reach-241338-billion-in-2018.aspx)